Similar articles

• Prevention of cervical cancer: where immunology meets diagnostics.

  Meijer CJ, Heideman DA, Berkhof H, Snijders PJ. Meijer CJ, et al. Immunol Lett. 2009 Feb 21;122(2):126-7. doi: 10.1016/j.imlet.2008.11.011. Epub 2008 Dec 25. Immunol Lett. 2009. PMID: 19100775
• [Vaccination against HPV in adults].

  Gil Á. Gil Á. Rev Esp Quimioter. 2009 Nov;22 Suppl 1:22-5. Rev Esp Quimioter. 2009. PMID: 20084345 Review. Spanish. No abstract available.
• Screening for cervical cancer: controversy and contention or thoughtful analysis.

  Frable WJ. Frable WJ. Cancer. 2007 Jun 25;111(3):143-4. doi: 10.1002/cncr.22752. Cancer. 2007. PMID: 17487849 No abstract available.
• [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].

  Delvenne P. Delvenne P. Bull Mem Acad R Med Belg. 2007;162(10-12):483-8; discussion 489-90. Bull Mem Acad R Med Belg. 2007. PMID: 18557390 French.
• A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.

  Jenkins D. Jenkins D. Gynecol Oncol. 2008 Sep;110(3 Suppl 1):S18-25. doi: 10.1016/j.ygyno.2008.06.027. Epub 2008 Jul 23. Gynecol Oncol. 2008. PMID: 18653221 Review.